share_log

CVS Health | 11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)

CVS Health | 11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)

西維斯健康 | 11-K:員工持股年度報告
美股SEC公告 ·  06/21 04:52

Moomoo AI 已提取核心訊息

CVS Health Corporation, through its CVS HEALTH FUTURE FUND 401(k) PLAN, has filed its annual report on Form 11-K for the fiscal year ended December 31, 2023, with the United States Securities and Exchange Commission. The independent audit, conducted by Ernst & Young LLP, concluded that the financial statements present fairly the net assets available for benefits and the changes in net assets available for benefits in conformity with U.S. generally accepted accounting principles. The report includes detailed financial statements, such as Statements of Net Assets Available for Benefits and Statements of Changes in Net Assets Available for Benefits, along with notes to the financial statements. The Plan's investments include mutual funds, common stock, corporate bonds, U.S. government securities, and...Show More
CVS Health Corporation, through its CVS HEALTH FUTURE FUND 401(k) PLAN, has filed its annual report on Form 11-K for the fiscal year ended December 31, 2023, with the United States Securities and Exchange Commission. The independent audit, conducted by Ernst & Young LLP, concluded that the financial statements present fairly the net assets available for benefits and the changes in net assets available for benefits in conformity with U.S. generally accepted accounting principles. The report includes detailed financial statements, such as Statements of Net Assets Available for Benefits and Statements of Changes in Net Assets Available for Benefits, along with notes to the financial statements. The Plan's investments include mutual funds, common stock, corporate bonds, U.S. government securities, and other securities, with total investments valued at $27,266,989,218. The Plan also holds synthetic guaranteed investment contracts valued at contract value. The Plan's assets and investment income have increased significantly compared to the previous year, reflecting a net increase in net assets for the year of $3,316,888,615. The Plan is subject to routine audits by taxing jurisdictions, and as of the report date, there are no audits for any tax periods in progress. The Plan's investments are managed by an independent investment consultant and approved by the Investment Subcommittee.
CVS HEALTH通過其CVS HEALTH FUTURE FUND 401(k) PLAN,向美國證券交易委員會提交截至2023年12月31日財年的Form 11-K年度報告。由Ernst & Young LLP進行的獨立審計認爲,財務報表依照美國通用會計原則公正地表明瞭可用福利淨資產和可用福利淨資產的變化。報告包括詳細的財務報表,例如可用福利淨資產表和可用福利淨資產變動表,以及財務報表附註。計劃的投資包括共同基金、普通股、公司債券、美國政府證券和其他證券,總投資價值爲27,266,989,218美元。計劃還持有合同價值爲合同價值的合成保證投資合同。計劃的資產和投資收益相比上年大幅增長,反映出年度淨資產增長了3,316,888,615美元。該計劃受到稅務轄區的例行審計,截至報告日期,沒有正在進行任何稅務週期的審計。計劃的投資由獨立投資顧問管理,並經投資小組批准。
CVS HEALTH通過其CVS HEALTH FUTURE FUND 401(k) PLAN,向美國證券交易委員會提交截至2023年12月31日財年的Form 11-K年度報告。由Ernst & Young LLP進行的獨立審計認爲,財務報表依照美國通用會計原則公正地表明瞭可用福利淨資產和可用福利淨資產的變化。報告包括詳細的財務報表,例如可用福利淨資產表和可用福利淨資產變動表,以及財務報表附註。計劃的投資包括共同基金、普通股、公司債券、美國政府證券和其他證券,總投資價值爲27,266,989,218美元。計劃還持有合同價值爲合同價值的合成保證投資合同。計劃的資產和投資收益相比上年大幅增長,反映出年度淨資產增長了3,316,888,615美元。該計劃受到稅務轄區的例行審計,截至報告日期,沒有正在進行任何稅務週期的審計。計劃的投資由獨立投資顧問管理,並經投資小組批准。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息